Greg Shaw
Angle announced today that it has appointed Greg Shaw to its scientific advisory board. Shaw is currently a consultant urological surgeon at the University College Hospital in London. He is also chief investigator for two studies at the National Institute for Health Research investigating the effects of refinements to robotic surgery and the use of drugs to prevent progression in men on active surveillance for prostate cancer.